Varenicline Tartrate APIs by Loncom Pharma offer a targeted approach to smoking cessation, acting as partial agonists at nicotine receptors and assisting in diminishing dependency on nicotine.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
